Wellington Management Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Wellington Management Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-11,354	Closed	-$1.13M	–	2404
2018 Q2	$1.13M	Buy	+11,354	New	+$981K	﹤0.01%	1863
2016 Q1	–	Sell	-2,041	Closed	-$290K	–	2298
2015 Q4	$290K	Buy	+2,041	New	+$236K	﹤0.01%	2050

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group's CBPO Position: Q3 2018 in Review

Wellington Management Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 11,354 shares — an estimated $1.13M sold.

Wellington Management Group first reported a position in CBPO in Q4 2015 and held it in 2 quarters. The position peaked at $1.13M in Q2 2018. 82 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

Wellington Management Group reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
Wellington Management Group sold 11,354 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $1.13M.
Wellington Management Group first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 2 quarters.
Wellington Management Group's China Biologic Products Holdings, Inc. position peaked at $1.13M in Q2 2018.
82 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on Wellington Management Group's 13F filing for Q3 2018, filed 14 Nov 2018.